Lineage-specific canonical and non-canonical activity of EZH2 in advanced prostate cancer subtypes.

Venkadakrishnan VB, Presser AG, Singh R, Booker MA, Traphagen NA, Weng K, Voss NCE, Mahadevan NR, Mizuno K, Puca L, Idahor O, Ku SY, Bakht MK, Borah AA, Herbert ZT, Tolstorukov MY, Barbie DA, Rickman DS, Brown M, Beltran H

Open source

DOI
10.1038/s41467-024-51156-5
Published
2024 Aug 8
Container
Nature communications
Publisher
Not recorded
Open access
yes

Credibility signals

limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1038/s41467-024-51156-5,
  title = {Lineage-specific canonical and non-canonical activity of EZH2 in advanced prostate cancer subtypes.},
  author = {Venkadakrishnan VB and Presser AG and Singh R and Booker MA and Traphagen NA and Weng K and Voss NCE and Mahadevan NR and Mizuno K and Puca L and Idahor O and Ku SY and Bakht MK and Borah AA and Herbert ZT and Tolstorukov MY and Barbie DA and Rickman DS and Brown M and Beltran H},
  year = {2024},
  journal = {Nature communications},
  doi = {10.1038/s41467-024-51156-5},
  url = {https://doi.org/10.1038/s41467-024-51156-5}
}

RIS

TY  - JOUR
TI  - Lineage-specific canonical and non-canonical activity of EZH2 in advanced prostate cancer subtypes.
AU  - Venkadakrishnan VB
AU  - Presser AG
AU  - Singh R
AU  - Booker MA
AU  - Traphagen NA
AU  - Weng K
AU  - Voss NCE
AU  - Mahadevan NR
AU  - Mizuno K
AU  - Puca L
AU  - Idahor O
AU  - Ku SY
AU  - Bakht MK
AU  - Borah AA
AU  - Herbert ZT
AU  - Tolstorukov MY
AU  - Barbie DA
AU  - Rickman DS
AU  - Brown M
AU  - Beltran H
PY  - 2024
JO  - Nature communications
DO  - 10.1038/s41467-024-51156-5
UR  - https://doi.org/10.1038/s41467-024-51156-5
ER  - 

APA

VB, V., AG, P., R, S., MA, B., NA, T., K, W., NCE, V., NR, M., K, M., L, P., O, I., SY, K., MK, B., AA, B., ZT, H., MY, T., DA, B., DS, R., M, B., & H, B. (2024). Lineage-specific canonical and non-canonical activity of EZH2 in advanced prostate cancer subtypes.. Nature communications. https://doi.org/10.1038/s41467-024-51156-5

Source records